# Epithelioid Haemangioendothelioma Observational Study

> **NCT06680401** · — · RECRUITING · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 50 (estimated)

## Conditions studied

- Clinical Presentation
- Natural History
- Treatment Outcomes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06680401
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-25
- **Primary completion:** 2028-02
- **Final completion:** 2028-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06680401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06680401, "Epithelioid Haemangioendothelioma Observational Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06680401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*